Strategies in Trauma and Limb Reconstruction

Register      Login

VOLUME 11 , ISSUE 1 ( April, 2016 ) > List of Articles

Original Article

External fixation reconstruction of the residual problems of benign bone tumours

Levent Eralp, F. Erkal Bilen, S. Robert Rozbruch, Mehmet Kocaoglu, Ahmed I. Hammoudi

Keywords : Benign bone tumours, External fixation, Limb reconstruction, Distraction osteogenesis, Shortening, Bone deformity

Citation Information : Eralp L, Bilen FE, Rozbruch SR, Kocaoglu M, Hammoudi AI. External fixation reconstruction of the residual problems of benign bone tumours. 2016; 11 (1):37-49.

DOI: 10.1007/s11751-016-0244-8

License: CC BY-NC-SA 4.0

Published Online: 01-12-2013

Copyright Statement:  Copyright © 2016; The Author(s).


Abstract

The mechanical features of and biologic response to using distraction osteogenesis with the circular external fixator are the unique aspects of Ilizarov's contribution that allows deformity correction and reconstruction of bone defects. We present a retrospective study of 20 patients who suffered from a variety of benign tumours for which external fixators (EF) were used to treat deformity, bone loss, and limb-length discrepancy. A total of 26 bony segments in twenty patients (10 males, 10 females; mean age 17 years; range 7–58 years) were treated with EF for residual problems from the tumour itself (primary treatment) in 8 patients and for complications related to the primary surgery (secondary treatment) in 12 patients. Histological diagnoses were Ollier's disease (n = 4), Fibrous Dysplasia (n = 5), Congenital multiple exostosis (n = 5), giant cell tumour (n = 2) and one case for chondromyxoid fibroma, desmoid fibroma, chondroma and unicameral bone cyst. Various types of external fixators used to treat these problems. These were Ilizarov, unilateral fixator, multiaxial correction frame (Biomet, Parsippany, NJ), Taylor spatial frame (Memphis, TN) and smart correction multiaxial frame. The mean follow-up time was 69.5 months (range 35–108 months). The mean external fixation time was 159.5 days (range 27–300 days). The mean external fixation index was 67.4 days/cm (12–610) in 26 limbs who underwent distraction osteogenesis. The mean length of distraction was 4.9 cm (range 0.2–14 cm). At final follow-up, all patients had returned to normal activities. Complications were in the form of knee arthrodesis in one patient, pin tract infection in six and residual shortening in eight patients. The use of EF and the principles of distraction osteogenesis, in the management of problems associated with benign bone tumours and related surgery yields successful results especially in young patients. With this approach, the risk for recurrence of shortening and deformity may be minimized with overcorrection or over-lengthening as dictated by preoperative planning.


PDF Share
  1. Donati D, Giacomini S, Gozzi E, Mercuri M (2002) Proximal femur reconstruction by an allograft prosthesis composite. Clin Orthop 394:192-200
  2. Eckardt JJ, Kabo JM, Kelley CM et al (2000) Expandable endoprosthesis reconstruction in skeletally immature patients with tumors. Clin Orthop 373:51-61
  3. Schaser KD, Bail HJ, Haas NP, Melcher I (2002) Treatment concepts of benign bone tumors and tumor-like bone lesions. Chirurg 73(12):1181-1190
  4. Tsuchiya H, Tomita K, Shinokawa Y et al (1996) The Ilizarov method in the management of giant-cell tumors of the proximal tibia. J Bone Joint Surg [Br] 78:264-269
  5. Tsuchiya H, Tomita K, Minematsu K et al (1996) Limb salvage using distraction osteogenesis: a classification of the technique. J Bone Joint Surg [Br] 78:403-411
  6. Enneking WF, Campanacci DA (2001) Retrieved human allografts: a clinico-pathological study. J Bone Joint Surg [Am] 83:971-986
  7. Shih LY, Chen TS, Lo WH (1993) Limb salvage surgery for locally aggressive and malignant bone tumors. J Surg Oncol 53:154-160
  8. Aronson James (1997) Current concepts review—limb-lengthening, skeletal reconstruction, and bone transport with the Ilizarov method. J Bone Joint Surg [Am] 79(8):1243-1258
  9. Atesalp AS, Basbozkurt M, Erler K et al (1998) Treatment of tibial bone defects with the Ilizarov circular external fixator in high-velocity gunshot wounds. Int Orthop 22:343-347
  10. Green SA (1991) Osteomyelitis: the Ilizarov perspective. Orthop Clin North Am 22:515-521
  11. Rozbruch SR, Herzenberg JE, Tetsworth K, Tuten HR, Paley D (2002) Distraction osteogenesis for nonunion after high tibial osteotomy. Clin Orthop 394:227-235
  12. Koseoglu E, Yildiz C, Atesalp AS, Basbozkurt M, Gur E (2000) Treatment of posttraumatic lower limb deformities with the Ilizarov method. Acta Orthop Traumatol Turc 34:480-487
  13. Canadell J, San-Julian M, Cara J, Forriol F (1998) External fixation in tumor pathology. Int Orthop 22:126-130
  14. Millett PJ, Lane JM, Paletta GA Jr (2000) Limb salvage using distraction osteogenesis. Am J Orthop 29:628-632
  15. Paley D, Catagni MA, Argnani F, Villa A, Benedetti GB, Cattaneo R (1989) Ilizarov treatment of tibial nonunions with bone loss. Clin Orthop 241:146-165
  16. Tsuchiya H, Morsy AF, Matsubara H, Watanabe K, Abdel-Wanis ME, Tomita K (2007) Treatment of benign bone tumours using external fixation. J Bone Joint Surg [Br] 89(8):1077-1083
  17. Erol B, Tetik C, Sirin E, Kocaoglu B, Bezer M (2006) Surgical treatment of hand deformities in multiple enchondromatosis: a case report. Acta Orthop Traumatol Turc 40:89-93
  18. Jesus-Garcia R, Bongiovanni JC, Korukian M et al (2001) Use of the Ilizarov external fixator in the treatment of patients with Ollier's disease. Clin Orthop 382:82-86
  19. Freeman BH, Bray EW 3rd, Meyer LC (1987) Multiple osteotomies with Zickel nail fixation for polyostotic fibrous dysplasia involving the proximal part of the femur. J Bone Joint Surg [Am] 69:691-698
  20. Funk F Jr, Well RE (1973) Hip problems in fibrous dysplasia. Clin Orthop 90:77-82
  21. Ozaki T, Sugihara M, Nakatsuka Y, Kawai A, Inoue H (1996) Polyostotic fibrous dysplasia: a long-term follow up of 8 patients. Int Orthop 20:227-232
  22. Edgerton MT, Persing JA, Jane JA (1985) The surgical treatment of fibrous dysplasia. With emphasis on recent contributions from cranio-maxillo-facial surgery. Ann Surg 202(4):459-479
  23. Guille JT, Kumar SJ, MacEwen GD (1998) Fibrous dysplasia of the proximal part of the femur: long-term results of curettage and bone-grafting and mechanical realignment. J Bone Joint Surg [Am] 80:648-658
  24. Jaffe HL (1958) Fibrous dysplasia. In: Tumors and tumorous conditions of the bones and joints. Lea and Febiger, Philadelphia, pp 117-142, 244-255
  25. Porter DE, Lonie L, Fraser M, Dobson-Stone C, Porter JR, Monaco AP, Simpson AH (2004) Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype- phenotype study. J Bone Joint Surg [Br] 86:1041-1046
  26. Noonan KJ, Feinberg JR, Levenda A, Snead J, Wurtz LD (2002) Natural history of multiple hereditary osteochondromatosis of the lower extremity and ankle. J Pediatr Orthop 22:120-124
  27. Watts AC, Ballantyne JA, Fraser M, Simpson AH, Porter DE (2007) The association between ulnar length and forearm movement in patients with multiple osteochondromas. J Hand Surg [Am] 32:667-673
  28. Pritchett JW (1986) Lengthening the ulna in patients with hereditary multiple exostoses. J Bone Joint Surg [Br] 68:561-565
  29. Thomas DM, Skubitz T (2009) Giant-cell tumor of bone. Curr Opin Oncol 21:338-344
  30. Dahlin DC, Cupps RE, Johnson EW Jr (1970) Giant-cell tumor: a study of 195 cases. Cancer 25:1061-1070
  31. Campanacci M, Cervellati C, Donati U (1985) Autogenous patella as replacement for a resected femoral or tibial condyle: a report on 19 cases. J Bone Joint Surg [Br] 67:557-563
  32. Cappana R, Fabbri N, Bettelli G (1990) Curettage of giant cell tumor of bone: the effect of surgical technique and adjuvants on local recurrence rate. Chir Organi Mov 75(Suppl 1):206
  33. Clohisy DR, Mankin HJ (1994) Osteoarticular allografts for reconstruction after resection of a musculoskeletal tumor in the proximal end of the tibia. J Bone Joint Surg [Am] 76:549-554
  34. Trieb K, Bitzan P, Lang S, Dominkus M, Kotz R (2001) Recurrence of curetted and bone grafted giant-cell tumors with and without adjuvant phenol therapy. Eur J Surg Oncol 27:200-202
  35. Balke M, Schremper L, Gebert C, Ahrens H, Streitbuerger A, Koehler G et al (2008) Giant cell tumor of bone: treatment and outcome of 214 cases. J Cancer Res Clin Oncol 134(9):969-978
  36. Gitelis S, Mallin BA, Piasecki P (1993) Intralesional excision compared with en bloc resection for giant-cell tumors of bone. J Bone Joint Surg [Am] 75(11):1648-1655
  37. Camargo OP, Croci AT, Oliveira CR, Baptista AM, Caiero MT (2005) Functional and radiographic evaluation of 214 aggressive benign bone lesions treated with curettage, cauterization, and cementation: 24 years of follow up. Clinics 60:439-444
  38. Blackley HR, Wunder JS, Davis AM et al (1999) Treatment of giant-cell tumors of long bones with curettage and bone-grafting. J Bone Joint Surg [Am] 81-A:811-820
  39. Méary R, Danan JP, Tomeno B, Forest M, Cirotteau Y (1978) Desmoid fibroma of the limbs. Rev Chir Orthop Reparatrice Appar Mot 64(3):195-204
  40. Lersundi A, Mankin HJ, Mourikis A, Hornicek FJ (2005) Chondromyxoid fibroma: a rarely encountered and puzzling tumor. Clin Orthop 439:171-175
  41. Vanni R (2003) Bone: chondroma. Atlas Genet Cytogenet Oncol Haematol 7(3):191-193
  42. Bensahel H, Jehanno P, Desgrippes Y, Pennecot GF (1998) Solitary bone cyst: controversies and treatment. J Pediatr Orthop B 7(4):257-261
  43. Wright JG, Yandow S, Donaldson S, Marley L (2008) A randomized clinical trial comparing intralesional bone marrow and steroid injections for simple bone cysts. J Bone Joint Surg [Am] 90(4):722-730
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.